Treatment-related AEs with an incidence of at least 10% in any grade category included alopecia (40, 100.0%), decreased white blood cells (22, 55.0%), decreased platelet count (18, 45.0%), decreased neutrophil count (15, 37.5%), increased γ-glutamyl transferase (13, 32.5%), anaemia (12, 30.0%), increased alkaline phosphatase (10, 25.0%), increased alanine aminotransferase (8, 20.0%), rash (5, 12.5%), increased aspartate aminotransferase (5, 12.5%), and increased creatinine (5, 12.5%). This evidence concerns the gene GPT and anemia (phenotype).